Detalles de la búsqueda
1.
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.
Br J Cancer
; 127(1): 79-83, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361918
2.
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 141-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25519041
3.
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study.
Breast
; 60: 70-77, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34488065
4.
Bevacizumab Combined with Platinum-Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients.
Cancers (Basel)
; 13(19)2021 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638225
5.
[Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?]. / Ist die Kardiotoxizität der Radiotherapie im Rahmen des Brusterhalts überhaupt noch relevant, und könnte sie durch Mehrfelder-IMRT gesenkt werden?
Strahlenther Onkol
; 185(4): 222-30, 2009 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-19370424
6.
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO).
J Cancer Res Clin Oncol
; 143(3): 541-550, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27896440
7.
Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial.
Breast Care (Basel)
; 6(6): 457-461, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22419900
8.
Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
Breast
; 17(6): 617-22, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650091
Resultados
1 -
8
de 8
1
Próxima >
>>